Literature DB >> 15967801

Mutations remote from the human gonadotropin-releasing hormone (GnRH) receptor-binding sites specifically increase binding affinity for GnRH II but not GnRH I: evidence for ligand-selective, receptor-active conformations.

Zhi-Liang Lu1, Ryan Gallagher, Robin Sellar, Marla Coetsee, Robert P Millar.   

Abstract

The human gonadotropin-releasing hormone (GnRH) receptor is evolutionarily configured for high affinity binding of GnRH I ([Tyr(5),Leu(7),Arg(8)]GnRH) but at lower affinity for GnRH II ([His(5),Trp(7),Tyr(8)]GnRH). GnRH I is more potent in the activation of the G(q/11) protein in the gonadotrope; however, GnRH II is more potent in the stimulation of apoptosis and antiproliferative effects through activating G(i) protein-mediated signaling, implying that GnRH I and II selectively stabilize different receptor-active conformations that preferentially couple to different signaling pathways. Receptor activation involves ligand induction or conformational selection, but the molecular basis of the communication between ligand-binding sites and receptor allosteric sites remains unclear. We have sought conformational coupling between receptor-ligand intermolecular interactions and intramolecular interaction networks in the human GnRH receptor by mutating remote residues that induce differential ligand binding affinity shifts for GnRH I and II. We have demonstrated that certain Ala mutations in the intracellular segments of transmembrane domains 3 (Met(132)), 5 (Met(227)), 6 (Phe(272) and Phe(276)), and 7 (Ile(322) and Tyr(323)) of the human GnRH receptor allosterically increased ligand binding affinity for GnRH II but had little effect on GnRH I binding affinity. We examined the role of the three amino acids that differ in these two ligands, and we found that Tyr(8) in GnRH II plays a dominant role for the increased affinity of the receptor mutants for GnRH II. We propose that creation of a high affinity binding site for GnRH II accompanies receptor conformational changes, i.e."induced fit" or "conformational selection," mainly determined by the intermolecular interactions between Tyr(8) and the receptor contact residues, which can be facilitated by disruption of particular sets of receptor-stabilizing intramolecular interactions. The findings suggest that GnRH I and II binding may selectively stabilize different receptor-active conformations and therefore different ligand-induced selective signaling described previously for these ligands.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967801     DOI: 10.1074/jbc.M413520200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  GnRH signaling, the gonadotrope and endocrine control of fertility.

Authors:  Stuart P Bliss; Amy M Navratil; Jianjun Xie; Mark S Roberson
Journal:  Front Neuroendocrinol       Date:  2010-05-06       Impact factor: 8.606

2.  Noninvasive analytical estimation of endogenous GnRH drive: analysis using graded competitive GnRH-receptor antagonism and a calibrating pulse of exogenous GnRH.

Authors:  Daniel M Keenan; Iain J Clarke; Johannes D Veldhuis
Journal:  Endocrinology       Date:  2011-10-25       Impact factor: 4.736

Review 3.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

4.  Hypothalamic gonadotropin-releasing hormone (GnRH) receptor neurons fire in synchrony with the female reproductive cycle.

Authors:  Christian Schauer; Tong Tong; Hugues Petitjean; Thomas Blum; Sophie Peron; Oliver Mai; Frank Schmitz; Ulrich Boehm; Trese Leinders-Zufall
Journal:  J Neurophysiol       Date:  2015-06-10       Impact factor: 2.714

5.  Exploring 3D structure of human gonadotropin hormone receptor at antagonist state using homology modeling, molecular dynamic simulation, and cross-docking studies.

Authors:  Amirhossein Sakhteman; Minasadat Khoddami; Manica Negahdaripour; Arash Mehdizadeh; Mohsen Tatar; Younes Ghasemi
Journal:  J Mol Model       Date:  2016-08-25       Impact factor: 1.810

6.  Functions of DPLIY motif and helix 8 of human melanocortin-3 receptor.

Authors:  Zhao Yang; Zhi-Li Huang; Ya-Xiong Tao
Journal:  J Mol Endocrinol       Date:  2015-07-28       Impact factor: 5.098

7.  Functions of acidic transmembrane residues in human melanocortin-3 receptor binding and activation.

Authors:  Shu-Xiu Wang; Zhen-Chuan Fan; Ya-Xiong Tao
Journal:  Biochem Pharmacol       Date:  2008-07-09       Impact factor: 5.858

Review 8.  Diversity of actions of GnRHs mediated by ligand-induced selective signaling.

Authors:  Robert P Millar; Adam J Pawson; Kevin Morgan; Emilie F Rissman; Zhi-Liang Lu
Journal:  Front Neuroendocrinol       Date:  2007-08-23       Impact factor: 8.606

9.  Gonadotropin-releasing hormone analog structural determinants of selectivity for inhibition of cell growth: support for the concept of ligand-induced selective signaling.

Authors:  Rakel López de Maturana; Adam J Pawson; Zhi-Liang Lu; Lindsay Davidson; Stuart Maudsley; Kevin Morgan; Simon P Langdon; Robert P Millar
Journal:  Mol Endocrinol       Date:  2008-05-08

10.  Role of the transmembrane domain 4/extracellular loop 2 junction of the human gonadotropin-releasing hormone receptor in ligand binding and receptor conformational selection.

Authors:  Rachel Forfar; Zhi-Liang Lu
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.